25 of the Best Oncologists Near Me

Jacob Laubach is an Oncologist and a Hematologist practicing medicine in Boston, Massachusetts. Dr. Laubach is highly rated in 15 conditions, according to our data. His clinical expertise encompasses Multiple Myeloma, Smoldering Multiple Myeloma, Relapsed Refractory Multiple Myeloma (RRMM), Bone Marrow Transplant, and Bone Marrow Aspiration. Dr. Laubach is board certified in Hematology, Internal Medicine, and Medical Oncology. Dr. Laubach is currently accepting new patients.

Evan Alley is a Hematologist Oncology provider practicing medicine in Stuart, Florida. Dr. Alley is highly rated in 15 conditions, according to our data. His clinical expertise encompasses Mesothelioma, Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), and Metastatic Pleural Tumor. Dr. Alley is board certified in American Board Of Internal Medicine, 2002. Dr. Alley is currently accepting new patients.

David Mcdermott is an Oncologist practicing medicine in Boston, Massachusetts. Dr. Mcdermott is highly rated in 15 conditions, according to our data. His clinical expertise encompasses Renal Cell Carcinoma (RCC), Melanoma, Chromophobe Renal Cell Carcinoma, WT1-Related Wilms Tumor Syndromes, and Nephrectomy. Dr. Mcdermott is board certified in American Board Of Internal Medicine. Dr. Mcdermott is currently accepting new patients.

Dr. Owen A. O'Connor is internationally renowned for his expertise on the diagnosis and treatment of all forms of lymphoma, with over 25 years of experience in academic medicine. He has invented and pioneered the development of several first in class drugs for the treatment of lymphoma, including one he co-invented for T-cell lymphoma which has now been approved in over 35 countries around the world. He has held several prestigious leadership positions at the major cancer centers in New York City, including Memorial Sloan Kettering Cancer Center, New York University Medical Center, and Cornell and Columbia University Medical Centers. Dr. O'connor is highly rated in 15 conditions, according to our data. His clinical expertise encompasses Peripheral T-Cell Lymphoma, T-Cell Lymphoma, Non-Hodgkin Lymphoma, and Anaplastic Large Cell Lymphoma. Dr. O'connor is currently accepting new patients.

I specialize in the treatment of gastrointestinal (GI) cancers with a focus on clinical trials. Clinical trial patients can come to me at any point during their disease, but they usually come to me looking for an alternative therapy once standard treatments have not been effective. I decided to become a doctor later in my career. I originally graduated from university with a non-science degree, but the excitement of advancing medical breakthroughs inspired me to start a career in medicine. As a Duke physician, I enjoy the diverse experiences that I get to have each week. In addition to taking care of patients and conducting research, I work closely with other doctors on crafting treatment plans. I also find it fulfilling to be able to apply my research to patient care. In my spare time, I enjoy spending time with my family, jogging and skiing. Dr. Strickler is highly rated in 15 conditions, according to our data. His clinical expertise encompasses Colorectal Cancer, Pancreatic Cancer, Stomach Cancer, and Familial Colorectal Cancer. Dr. Strickler is board certified in American Board Of Internal Med, Internal Medicine and American Board Of Internal Med, Medical Oncology. Dr. Strickler is currently accepting new patients.

Ana De Jesus-Acosta is an Oncologist practicing medicine in Baltimore, Maryland. Dr. De Jesus-Acosta is highly rated in 15 conditions, according to our data. Her clinical expertise encompasses Pancreatic Cancer, Neuroendocrine Tumor, Pancreatic Islet Cell Tumor, Pancreaticoduodenectomy, and Pancreatectomy. Dr. De Jesus-Acosta is board certified in American Board Of Internal Medicine. Dr. De Jesus-Acosta is currently accepting new patients.

I am a medical oncologist who specializes in the treatment of patients with skin cancer. I am part of a team of surgical oncologists, dermatologists, and radiation oncologists who all work together to determine the best treatment approach for each patient. My focus is on treating patients with advanced melanoma, as well as melanoma that is at high risk for recurrence after surgery. We also treat patients with merkel cell carcinoma and advanced basal cell and cutaneous squamous cell carcinoma. We also have a number of clinical trial options available, allowing our patients access to the newest therapies available. Dr. Salama is highly rated in 15 conditions, according to our data. Her clinical expertise encompasses Melanoma, Melanoma of the Eye, Metastatic Uveal Melanoma, Primitive Neuroectodermal Tumor (PNET), and Vulvectomy. Dr. Salama is currently accepting new patients.

Veena John, MD, is the System Head for GYN/Medical Oncology for the Northwell Health Cancer Institute and an Assistant Professor of Medicine in the Donald and Barbara Zucker School of Medicine at Hofstra/Northwell. Board certified in Internal Medicine, Hematology and Medical Oncology, she maintains an active practice caring for patients with gynecologic cancers where she focuses on providing compassionate, personalized, evidence-based multi-disciplinary care. In conjunction with physicians in Surgical Oncology, she pioneered a multi-disciplinary team approach for gynecologic oncology patients at the R.J. Zuckerberg Cancer Center where her practice is based. Dr. John is a highly experienced principal investigator for industry sponsored Phase I, II and III clinical trials in gynecologic oncology. She is the site principal investigator for the NRG cooperative group for the Northwell Health Cancer Institute and co-chair of the protocol review monitoring committee. Dr. John earned her medical degree from Christian Medical College in India, where she also completed her internal medicine internship. She completed her internal medicine residency at Flushing Medical Center and fellowship in hematology and medical oncology at North Shore University Hospital. She is an active member of the Society for Gynecologic Oncology, Society for Immunotherapy in Cancer, American Society of Clinical Oncology and American Society of Hematology as well as a member of the Ovarian Cancer committee for the national Gynecologic Oncology Group. Dr. John is highly rated in 15 conditions, according to our data. Her clinical expertise encompasses Ovarian Cancer, Endometrial Cancer, Testicular Yolk Sac Tumor, and Malignant Mixed Mullerian Tumor. Dr. John is board certified in American Board Of Internal Medicine/Medical Oncology, American Board Of Internal Medicine, and American Board Of Internal Medicine/Hematology. Dr. John is currently accepting new patients.

Dr. Misop Han is David Hall McConnell Professor of Urology and Oncology at the Johns Hopkins School of Medicine. Dr. Han is a urologist whose main clinical focus is in urological oncology with a special emphasis on prostate and kidney cancers. He specializes in robotic nerve-sparing prostatectomy and robotic nephrectomy. Dr. Han received his undergraduate and medical degrees at Johns Hopkins. After an internship in surgery and residency in urology, also at Johns Hopkins, he worked as faculty at Northwestern University and Hospital in Chicago, Illinois. In 2006, he joined the Johns Hopkins faculty. His research interests include the outcome of radical prostatectomy, medical robotics and prediction modeling (what happens to men following surgery for prostate cancer). He has published extensively in these subjects and has received international and national recognition for his research. He is actively involved in several clinical research projects with the database of more than 20,000 men who received surgery for prostate cancer at The Johns Hopkins Hospital. He is a member of the American Urological Association and the American Medical Association. Dr. Han is highly rated in 15 conditions, according to our data. His clinical expertise encompasses Prostate Cancer, Ureterocele, Familial Prostate Cancer, Prostatectomy, and Nephrectomy. Dr. Han is board certified in American Board Of Urology. Dr. Han is currently accepting new patients.

Timothy Carey is a Hematologist Oncology provider practicing medicine in Braselton, Georgia. Dr. Carey is highly rated in 15 conditions, according to our data. His clinical expertise encompasses Paget Disease of the Breast, Inflammatory Breast Cancer, Multiple Myeloma, and Lung Cancer. Dr. Carey is board certified in American Board Of Internal Medicine, Hematology - 2007. Dr. Carey is currently accepting new patients.

Dr. Sreeram Maddipatla is a triple-board-certified oncologist and hematologist with the Orlando Health Cancer Institute Liver Center and Pancreas Center. His specialties include: Colon cancer Pancreatic cancer Stomach and esophageal cancer Liver cancer Lymphoma Prostate cancer Bladder cancer Testicular cancer Lung cancer Breast cancer Benign hematology such as anemias Dr. Maddipatla strives to care for each patient the way he would want to be treated. Dr. Maddipatla's Training Dr. Maddipatla received his medical training at Sri Devaraj Urs Medical College in Bangalore, India, and his Master of Public Health (MPH) from the University of North Texas Health Science Center at Fort Worth. He completed an internal medicine residency at the State University of New York in Buffalo and a fellowship in hematology and oncology at MD Anderson Cancer Center in Orlando. About Dr. Maddipatla Dr. Maddipatla is board certified in internal medicine, hematology and oncology by the American Board of Internal Medicine. His professional memberships include the American College of Physicians, American Society of Clinical Oncology and American Society of Hematology. Dr. Maddipatla has presented his research at national conferences and has published articles in peer-reviewed journals, including Clinical Cancer Research and Oncology. He has also received several awards, like Outstanding Master's in Public Health (MPH) student award at the University of North Texas, Fort Worth, Texas, recipient of the Dinah Kukes Cancer Memorial Fund Grant, Exemplary Physician Colleague award from Orlando Health and the Golden Apple Award - Practice of Medicine Preceptor award for excellence in teaching from the University of Central Florida. Dr. Maddipatla also contributes to the American Board of Internal Medicine as a question writer for hematology board exams. Outside of work, he enjoys tennis, traveling and reading. Dr. Maddipatla is fluent in English, Hindi and Telugu. Dr. Maddipatla is highly rated in 15 conditions, according to our data. His clinical expertise encompasses Familial Colorectal Cancer, Colorectal Cancer, Sickle Cell Disease, and Prostate Cancer. Dr. Maddipatla is board certified in American Board Of Internal Medicine - Hematology, American Board Of Internal Medicine, and American Board Of Internal Med. - Medical Oncology. Dr. Maddipatla is currently accepting new patients.

Dr. O'Shaughnessy is a Medical Oncologist that focuses on breast cancer prevention and treatment. She founded The School of Breast Oncology, a program providing a curriculum-based program focused exclusively on breast cancer clinical management. Dr. O'Shaughnessy attended medical school at Yale University School of Medicine in New Haven, CT. She then completed her Internal Medicine residency at Massachusetts General Hospital in Boston, MA and a Medical Oncology fellowship at National Cancer Institute in Bethesda, MD. She is co-chair of Breast Cancer Research, chair of Breast Cancer Prevention Research at Baylor Charles A. Sammons Cancer Center and a member of the Scientific Advisory Board for US Oncology Research Network. Dr. O'shaughnessy is highly rated in 14 conditions, according to our data. Her clinical expertise encompasses Breast Cancer, Triple-Negative Breast Cancer, PIK3CA-Related Overgrowth Spectrum, Inflammatory Breast Cancer, and Tissue Biopsy. Dr. O'shaughnessy is board certified in Medical Oncology- American Board Of Internal Medicine, Medical Oncology- American Board Of Internal Med/Medical Oncology, Internal Medicine- American Board Of Internal Med, and Internal Medicine- American Board Of Internal Medicine. Dr. O'shaughnessy is currently accepting new patients.

Daniel Costa is an Oncologist practicing medicine in Boston, Massachusetts. Dr. Costa is highly rated in 14 conditions, according to our data. His clinical expertise encompasses EGFR Positive Lung Cancer, Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), and Lung Adenocarcinoma. Dr. Costa is board certified in American Board Of Internal Medicine. Dr. Costa is currently accepting new patients.

Dr. Max Kates is the R. Christian B. Evensen Professor and an associate professor of urology and oncology at the Brady Urological Institute at Johns Hopkins. He also directs the Division of Urologic Oncology for the Brady Urological Institute. Dr. Kates completed his undergraduate degree at Wesleyan University in Connecticut before pursuing his medical degree at Mount Sinai School of Medicine in New York. He then went on to train at Johns Hopkins for his urologic residency and Society of Urologic Oncology (SUO) fellowship. Dr. Kates has expertise in all areas of urologic oncology, with a particular emphasis on bladder and prostate cancer. With training in open, endoscopic, and robotic surgical approaches, Dr. Kates’ surgical philosophy is to assess the unique needs of each patient, and develop the right treatment plan for their malignancy. He is very hands on in his approach in the clinic and the operating room, and believes open communication with the patient, the patient’s family, and referring providers is key to ensuring a speedy recovery. As the clinical director of the bladder cancer multidisciplinary clinic, Dr. Kates works with the team at the Johns Hopkins Greenberg Bladder Cancer Institute to deliver a personalized approach to bladder cancer utilizing cutting edge precision medicine approaches. Dr. Kates’ research interests involve novel treatments for cancers of the urinary tract. Dr. Kates has authored more than 135 journal articles in the fields of bladder, prostate, and kidney cancer. He currently has a provisional patent for a novel intravesical chemotherapy developed with nano-engineer collaborators. Additionally, Dr. Kates has made important discoveries into the mechanism of action of intravesical BCG, the most common treatment for bladder cancer. He is the principal investigator on multiple trials, and is currently leading EA8212 BRIDGE, which is a randomized trial open in over 150 centers in the United States comparing BCG to GemDoce chemotherapy for early stage bladder cancer. To inquire about an appointment or make a referral, Dr. Kates can be contacted by phone (410) 614-0009. Dr. Kates is highly rated in 14 conditions, according to our data. His clinical expertise encompasses Bladder Cancer, Urothelial Cancer, Muscle Invasive Bladder Cancer, Cystectomy, and Nephrectomy. Dr. Kates is board certified in American Board Of Urology. Dr. Kates is currently accepting new patients.

Dr. Partridge received her MD from Cornell University Medical College in 1995. She completed her residency in internal medicine at the Hospital of the University of Pennsylvania and went on to complete fellowships in medical oncology and hematology at DFCI, MGH and BWH. She also received an MPH from Harvard School of Public Health. She is a medical oncologist who cares for adults with breast cancer, with a particular focus on the unique needs of young patients with breast cancer. She also leads efforts to optimize cancer survivorship care and research at DFCI. She completed fellowships in Medical Oncology and Hematology at DFCI, Massachusetts General Hospital and Brigham and Women’s Hospital. Dr. Partridge is highly rated in 14 conditions, according to our data. Her clinical expertise encompasses Breast Cancer, Inflammatory Breast Cancer, BRCA Positive Breast Cancer, Hormone Replacement Therapy (HRT), and Salpingo-Oophorectomy. Dr. Partridge is board certified in Medical Oncology. Dr. Partridge is currently accepting new patients.

Asim Amin is an Oncologist practicing medicine in Charlotte, North Carolina. Dr. Amin is highly rated in 14 conditions, according to our data. His clinical expertise encompasses Renal Cell Carcinoma (RCC), Melanoma, Clear Cell Sarcoma, and WT1-Related Wilms Tumor Syndromes. Dr. Amin is board certified in American Board Of Internal Medicine and American Board Of Internal Medicine, Medical Oncology. Dr. Amin is currently accepting new patients.

Brendan Curti is an Oncologist practicing medicine in Portland, Oregon. Dr. Curti is highly rated in 14 conditions, according to our data. His clinical expertise encompasses Melanoma, Renal Cell Carcinoma (RCC), Prostate Cancer, and Metastatic Uveal Melanoma. Dr. Curti is currently accepting new patients.

Tara Kent is an Oncologist practicing medicine in Boston, Massachusetts. Dr. Kent is highly rated in 14 conditions, according to our data. Her clinical expertise encompasses Pancreatic Cancer, Familial Pancreatic Cancer, Ampullary Cancer, Pancreatectomy, and Pancreaticoduodenectomy. Dr. Kent is board certified in American Board Of Surgery. Dr. Kent is currently accepting new patients.

David Kamson is an Oncologist practicing medicine in Baltimore, Maryland. Dr. Kamson is highly rated in 14 conditions, according to our data. His clinical expertise encompasses Brain Tumor, Metastatic Brain Tumor, Glioblastoma, Glioma, and Hormone Replacement Therapy (HRT). Dr. Kamson is board certified in American Board Of Psychiatry And Neurology. Dr. Kamson is currently accepting new patients.

Cancer is a terrible disease—often one of the most frightening and uncertain experiences a person can face. My philosophy is to approach every patient with a blend of deep empathy and evidence-based treatment options, empowering them to make informed decisions that align with their values, needs, and goals. I believe that compassionate care and scientific rigor form the foundation of meaningful, personalized cancer care. Dr. Santana is highly rated in 14 conditions, according to our data. His clinical expertise encompasses Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), Small Cell Lung Cancer (SCLC), and Pleuropulmonary Blastoma. Dr. Santana is board certified in American Board Of Internal Medicine. Dr. Santana is currently accepting new patients.

I am passionate about offering patients with gynecologic cancer the most cutting-edge surgery and medical therapies. My research and clinical endeavors have focused on the development of novel surgical interventions, robotic surgery and the incorporation of technology to improve cancer outcomes, minimize the recovery from surgery, and decrease complications and side effects. I treat patients with all forms of gynecologic cancers and also offer surgery for complex benign gynecologic conditions. I derive great pleasure from establishing long-term relationships with patients throughout their cancer journey. When not at work, I enjoy cooking, running with my dog, Lucy, and spending time with my husband and sons. Dr. Rossi is highly rated in 14 conditions, according to our data. Her clinical expertise encompasses Endometrial Cancer, Cervical Cancer, Neuroendocrine Carcinoma of the Cervix, Lymphadenectomy, and Hysterectomy. Dr. Rossi is board certified in American Board Of Obstetrics/Gynecology, Gynecologic Oncology and American Board Of Obstetrics/Gynecology, Obstetrics & Gynecology. Dr. Rossi is currently accepting new patients.

Christina Chu is an Oncologist and a Hematologist Oncology provider practicing medicine in Camden, New Jersey. Dr. Chu is highly rated in 14 conditions, according to our data. Her clinical expertise encompasses Ovarian Cancer, Endometrial Cancer, Ovarian Carcinosarcoma, and Sertoli-Leydig Cell Tumor. Dr. Chu is board certified in American Board Of Obstetrics And Gynecology,Gynecologic Oncology , 2006 and American Board Of Obstetrics And Gynecology,Obstetrics And Gynecology , 2004.

Benjamin Teply is an Oncologist practicing medicine in Omaha, Nebraska. Dr. Teply is highly rated in 14 conditions, according to our data. His clinical expertise encompasses Prostate Cancer, Familial Prostate Cancer, Clear Cell Sarcoma, Hormone Replacement Therapy (HRT), and Tissue Biopsy. Dr. Teply is currently accepting new patients.

Shams Bufalino is a Hematologist and an Oncologist practicing medicine in Park Ridge, Illinois. Dr. Bufalino is highly rated in 14 conditions, according to our data. Her clinical expertise encompasses Large-Cell Immunoblastic Lymphoma, Diffuse Large B-Cell Lymphoma (DLBCL), Hodgkin Lymphoma, Classical Hodgkin Lymphoma, and Bone Marrow Aspiration. Dr. Bufalino is board certified in American Board Of Internal Medicine, Hematology. Dr. Bufalino is currently accepting new patients.

Dr. Lin is a medical oncologist specializing in the care of patients with all stages of breast cancer. Her research focuses upon improving the outcomes of people living with metastatic breast cancer, including a particular focus on the challenge of breast cancer brain metastases. She has led multiple clinical trials which have led to new treatment options for patients with breast cancer that has metastasized to the brain. Dr. Lin received her MD from Harvard Medical School in 1999. She completed her residency in internal medicine at Brigham and Women's Hospital and went on to complete fellowships in medical oncology and hematology at Dana-Farber. In 2005, she joined the staff of Brigham and Women's and Dana-Farber, where she is a medical oncologist and clinical investigator in the Breast Oncology Center. Dr. Lin is highly rated in 13 conditions, according to our data. Her clinical expertise encompasses Breast Cancer, HER-2 Positive Breast Cancer, Brain Tumor, and Inflammatory Breast Cancer. Dr. Lin is board certified in Medical Oncology. Dr. Lin is currently accepting new patients.